DP₂ receptor antagonists in development

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.8, 2010-08, pp. : 947-961

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of WO2012078210 – development process for the preparation of a DP2 receptor antagonist; Ironwood's first development DP2 antagonist

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1257-1261

Informa Healthcare

Access to resources Recommend Favorite

The use of DP receptor antagonists to treat allergic rhinitis

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 597-599

Informa Healthcare

Access to resources Recommend Favorite

Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs

By Norman Peter

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

CCK₂ receptor antagonists

By McDonald I.M.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 3, 2001-03 ,pp. : 445-462

Informa Healthcare

Access to resources Recommend Favorite

Development of IL-5 Receptor Antagonists

Current Pharmaceutical Design, Vol. 8, Iss. 20, 2002-09 ,pp. : 1837-1844

Bentham Science Publishers

Access to resources Recommend Favorite